Hyperuricemia Is an Independent Risk Factor for New Onset Micro-Albuminuria in a Middle-Aged and Elderly Population: A Prospective Cohort Study in Taiwan

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Chang, Hung Yu ^a   Lee, Pei Hsien ^a   Lei, Chen Chou ^a   Tung, Chun Wu ^a,b   Hsu, Yung Chien ^a   Huang, Tung Jung ^a   Lu, Long chuan ^c   Lin, Chun Liang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COHORT ANALYSIS; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROSPECTIVE STUDY; RISK FACTOR; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID URINE LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINURIA; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TAIWAN; URIC ACID;

EID: 84876529684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061450     Document Type: Article

References (42)

1. Baker JF, Krishnan E, Chen L, Schumacher HR, (2005) Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 118: 816-826.
2. Fang J, Alderman MH, (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283: 2404-2410.
3. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, et al. (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164: 1546-1551.
4. Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T, (2011) Elevated serum uric acid predicts chronic kidney disease. Am J Med Sci 342: 461-466.
5. Rao GN, Corson MA, Berk BC, (1991) Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266: 8604-8608.
6. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, et al. (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26: 269-275.
7. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, et al. (2002) Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110.
8. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, et al. (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282: F991-F997.
9. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, et al. (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897.
10. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, et al. (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44: 642-650.
11. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, et al. (2008) Uric acid and incident kidney disease in the community. J Am Soc Nephrol 19: 1204-1211.
12. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, et al. (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19: 2407-2413.
13. Culleton BF, Larson MG, Kannel WB, Levy D, (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131: 7-13.
14. Bakris GL, (2008) Slowing nephropathy progression: Focus on proteinuria reduction. Clin J Am Soc Nephrol 3: S3-S10.
15. Matthew R. Weir (2007) Microalbuminuria and Cardiovascular Disease. Clin J Am Soc Nephro 2: 581-590.
16. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, et al. (1996) Development and Progression of Renal Disease in Pima Indians with Non-Insulin-Dependent Diabetes Mellitus. N Engl J Med 335: 1636-1642.
17. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426.
18. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, et al. (2005) Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 112: 969-975.
19. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, et al. (2004) Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 33: 189-198.
20. Chang HY, Tung CW, Lee PH, Lei CC, Hsu YC, et al. (2010) Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci 339: 509-515.
21. Cravedi P, Ruggenenti P, Remuzzi G, (2012) Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol 8: 301-306.
22. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002) Am J Kidney Dis 392 Suppl 1: S1-266.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
24. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
25. Kaplan NM, (1998) The 6th joint national committee report (JNC-6): new guidelines for hypertension therapy from the USA. Keio J Med 47: 99-105.
26. American Diabetes Association position statement (2003) Diabetic nephropathy. Diabetes Care 26: S94-S98.
27. Chang HY, Pan WH, Yeh WT, Tsai KS, (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey inTaiwan (1993-96). J Rheumatol 28: 1640-1646.
28. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174.
29. Kurella M, Lo JC, Chertow GM, (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140.
30. Kang DH, Nakagawa T, Feng L, Wantanase S, Han L, et al. (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897.
31. Sanchez-lozada LG, Tapia E, Avila-casado C, Virgilia S, Martha F, et al. (2002) Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 283: F1105-F1110.
32. Nakagawa T, Mazzali M, Kang DH, Kanellis J, Watanabe S, et al. (2003) Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 23: 2-7.
33. Hovind P, Rossing P, Johnson RJ, Parving HH, (2011) Serum uric acid as a new player in the development of diabetic nephropathy. J Ren Nutr 21: 124-127.
34. Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, et al. (2013) An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res 36: 43-49.
35. Resl M, Clodi M, Neuhold S, Kromoser H, Riedl M, et al. (2012) Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet Med 29: 721-725.
36. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, et al. (2006) Serum uric acid as associated with microalbuminuria in prehypertension Hypertension. 47: 962-967.
37. Tseng CH, (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68: 796-801.
38. Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP, (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121: 11-18.
39. Rodrigues SL, Baldo MP, Capingana P, Magalhes P, Dantas EM, et al. (2012) Gender distribution of serum uric acid and cardiovascular risk factors: population based study. Arq Bras Cardiol 98: 13-21.
40. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, et al. (2006) Uric acid and the development of hypertension: the normative aging study. Hypertension 48: 1031-1036.
41. Siu YP, Leung KT, Tong MK, Kwan TH, (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47: 51-59.
42. Goicoechea M, de Vinuesa SG, Verdalle U, Ruiz-Caro C, Ampuero J, et al. (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5: 1388-1393.